IL15 and COVID-19: Additional monocyte-related mechanisms contributing to NK cell dysfunction may be represented by a reduced secretion of IL-12 and IL-15, two cytokines that sustain NK cell activity and that are markedly reduced in the serum of severe COVID-19 patients (85).